Sorafenat Tablets

Sorafenat Tablets Specification

Indication
Treatment of advanced renal cell carcinoma and unresectable hepatocellular carcinoma

Origin
India

Dosage Form
Tablet

Salt Composition
Sorafenib Tosylate

Enzyme Types
Sorafenat Tablets

Feature
Anticancer, pharmaceutical grade

Ingredients
Each tablet contains Sorafenib Tosylate equivalent to Sorafenib 200 mg

Application
Oral administration under medical supervision for cancer therapy

Physical Color/Texture
Light yellow, film-coated tablets

Fermentation Smell
Odorless

Storage Instructions
Cool & Dry Place

Shelf Life
24 to 36 months

Market Authorization Holder
Natco Pharma Ltd.

Packaging Type
Bottle

Therapeutic Class
Anti-neoplastic agent

Prescription
Required

Drug Class
Multi-kinase inhibitor

Packaging Size
120 tablets per bottle

Strength
200 mg

ATC Code
L01XE05

Brand Name
Sorafenat

Route of Administration
Oral

Sorafenat Tablets Trade Information

Minimum Order Quantity
5000 Pieces

Supply Ability
100 Pieces Per Day

Delivery Time
3-4 Days

Main Export Market(s)
Australia, Western Europe, Asia, Eastern Europe, Central America, Africa, North America, South America, Middle East

Main Domestic Market
All India

About Sorafenat Tablets

Buy Sorafenat Tablets, a rare and sought-after anti-neoplastic agent from Natco Pharma Ltd., India. Each bottle contains 120 light yellow, film-coated, odorless tablets, each loaded with Sorafenib Tosylate 200 mg. Designed as a valiant solution for the treatment of advanced renal cell carcinoma and unresectable hepatocellular carcinoma, Sorafenat is prescribed for oral use under medical supervision. Its customizable, pharmaceutical-grade formulation ensures superior efficacy. Store in a cool, dry place. Sorafenat exemplifies lofty standards for cancer therapy, suitable for exporters, suppliers, and traders seeking a powerful, multi-kinase inhibitor.

Therapeutic Use & Application Media

Sorafenat Tablets are primarily used in the management of advanced renal cell carcinoma and unresectable hepatocellular carcinoma. These film-coated tablets offer a robust, valiant solution in oncology and are prescribed for oral administration. Their rare, customizable anti-cancer formulation is enhanced for superior absorption and performance. Sorafenat stands out as a preferred therapy in major medical centers, offering extra features such as a long shelf life and suitability for various pharmacy and hospital settings.

Supply Ability, Competitive Pricing & Export Markets

Our supply of Sorafenat Tablets is consistent and reliable, supporting large orders for pharmaceutical exporters. We guarantee the lowest price in the market and competitive list pricing to meet a wide range of purchasing needs. Products are dispatched promptly with secure packaging to ensure integrity during transit. Sorafenat is exported mainly to global markets in Asia, Africa, and the Middle East. Flexible payment terms provide ease of transactions for buyers worldwide.

FAQ's of Sorafenat Tablets:

Q: How should Sorafenat Tablets be administered?

A: Sorafenat Tablets must be taken orally, exactly as prescribed by a qualified healthcare professional, typically on an empty stomach or as directed.

Q: What is the primary benefit of using Sorafenat Tablets?

A: Sorafenat is specifically indicated for treating advanced renal cell carcinoma and unresectable hepatocellular carcinoma, offering a multi-kinase inhibitor effect for improved patient outcomes.

Q: When is a prescription required for Sorafenat Tablets?

A: A valid medical prescription is mandatory before purchasing Sorafenat, ensuring the dosage and administration are suitable for each patient's clinical condition.